Additionally, we revealed that FGFRL1 modulates chemoresistance of SCLC by regulating the ENO1‐PI3K/Akt pathway via combining to ENO1 in SCLC cells (Figure 7). This evidence concerns the gene AKT1 and small cell lung carcinoma.